BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
Client Focus
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Healthcare
Bryan, Garnier & Co advises Cellectis on its acquisition of Cellartis and EUR 50 million capital increase
€8 million capital raising for PVP Laboratoires SEBBIN Funding led by new investors VENTECH, Idinvest Partners and Sigma Gestion
Bryan, Garnier & Co advised bioMérieux in the acquisition of AES Laboratoire
Bryan, Garnier & Co advises Silliker on its disposal of Dr. A. Verwey
Success of the initial public offering of Zealand Pharma
Bryan, Garnier & Co advised Synthetech in its sale to W. R. Grace & Co
Bryan, Garnier & Co successfully leads Novagali Pharma €22m IPO
Bryan, Garnier & Co leads a Eur 152m capital increase for Transgene
Bryan, Garnier & Co successfully leads €6.7 million IPO for Integragen
Bryan, Garnier & Co leads a € 24,3 m capital increase for Innate Pharma
1
…
14
15
16
17
18
Privacy Preference Center
Privacy Preferences